Cancer Prevention Pharmaceuticals

Cancer Prevention Pharmaceuticals, Inc. (CPP) is a biopharmaceutical company developing cancer prevention therapies that will effectively and safely reduce the risk of cancer for people with elevated risk. The Company is initially focused on Familial Adenomatous Polyposis (FAP) which is a precursor to colon cancer. CPP works collaboratively with the National Cancer Institute (NCI) and multiple academic partners